Cite
HARVARD Citation
Sheridan, J. et al. (2018). Protocol for a multicentred randomised controlled trial investigating the use of personalised golimumab dosing tailored to inflammatory load in ulcerative colitis: the GOAL-ARC study (GLM dose Optimisation to Adequate Levels to Achieve Response in Colitis) led by the INITIAtive group (NCT 0268772). BMJ open gastroenterology. 5 (1), p. . [Online].